Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)
Dupilumab治疗中重度特应性皮炎青少年患者的长期疗效和安全性:一项III期开放标签扩展试验(LIBERTY AD PED-OLE)第52周的结果
期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-022-00683-2
Blauvelt, Andrew; Guttman-Yassky, Emma; Paller, Amy S; Simpson, Eric L; Cork, Michael J; Weisman, Jamie; Browning, John; Soong, Weily; Sun, Xian; Chen, Zhen; Kosloski, Matthew P; Kamal, Mohamed A; Delevry, Dimittri; Chuang, Chien-Chia; O'Malley, John T; Bansal, Ashish